Quanterix appoints Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors

Quanterix Corp

Dr. Magovčević-Liebisch appointed effective Oct 2, 2024 as Class III director with term expiring at 2026 annual meeting.
Received initial equity award valued at $400,000 (60% stock options, 40% RSUs) vesting over three years.
She serves as President and CEO of Vigil Neuroscience, with over 25 years biopharma experience.
Appointed to the Compensation Committee of the Board.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ivana Magovčević-Liebisch

Director

QTRX · Quanterix Corp

Effective: 2024-10-02
Filed: October 3, 2024, 7:59 PM ET

appointed Ivana Magovčević-Liebisch, Ph.D., J.D. to serve on the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ivana Magovčević-Liebisch was appointed as Director at Quanterix Corp.

Action: appointed
Role: Director

Exact text from the filing

appointed Ivana Magovčević-Liebisch, Ph.D., J.D. to serve on the Board effective immediately.

View on SEC.gov

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001628280-24-042118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.